ISSN : 2575-7725
Stem-cell therapy specially the umbilical cord-mesenchymal stem cells (UC-MSCs) is a emerging alternative to treat progressing tissue damage by reorganising the underlying disease process and to repair injured tissues, home to inflamed sites and involves least ethical concerns. Numerous questions need to be justified before MSCs derived from UC and their conditioned-medium can be applicable for the therapy of diverse diseases/conditions.
Journal of Stem Cell Biology and Transplantation received 80 citations as per Google Scholar report